Biogen Inc.

11/22/2021 | Press release | Distributed by Public on 11/22/2021 10:09

Statement on JAMA Neurology Publication about Amyloid-Related Imaging Abnormalities in Two Phase 3 Studies Evaluating Aducanumab in Early Alzheimer’s Disease